Dextromethorphan in Cough Syrup: The Poor Man's Psychosis.
Bridgette Martinak, Ramy A Bolis, J. Black, Rachel E. Fargason, Badari Birur
Psychopharmacology Bulletin August 12, 2025 DOI: 10.64719/pb.4553 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | 40-year-old Caucasian female with severe dextromethorphan use disorder and dextromethorphan-induced psychotic disorder |
| Intervention | antipsychotic and mood stabilizer |
| Key findings | A patient's dextromethorphan-induced psychotic disorder remitted only after treatment with a combination of an antipsychotic and mood stabilizer. |
Abstract
Dextromethorphan (3-methoxy-N-methylmorphinan), also known as "DXM" and "the poor man's PCP," is a synthetically produced drug that is available in more than 140 over-the-counter cough and cold preparations. Dextromethorphan (DXM) has overtaken codeine as the most widely used cough suppressant due to its availability, efficacy, and safety profile at directed doses. However, DXM is subject to abuse. When consumed at inappropriately high doses (over 1500 mg/day), DXM can induce a state of psychosis characterized by Phencyclidine (PCP)-like psychological symptoms, including delusions, hallucinations, and paranoia. We report a noteworthy case of severe dextromethorphan use disorder with dextromethorphan-induced psychotic disorder in a 40-year-old Caucasian female, whose symptoms remitted only following treatment with a combination of an antipsychotic and mood stabilizer. While some states have begun to limit the quantity of DXM sold or restrict sales to individuals over 18-years of age, there is currently no federal ban or restriction on DXM. Abuse of DXM, a readily available and typically inexpensive agent that is not detected on a standard urine drug screen, may be an under-recognized cause of substance-induced psychosis. It is imperative that clinicians are aware of the potential psychiatric sequelae of recreational DXM use.
Citations in the library
Cited by 8
- The abuse liability of ketamine: A scoping review of preclinical and clinical studies. Journal of Psychiatric Research May 1, 2022
- Efficacy of dextromethorphan for the treatment of depression: a systematic review of preclinical and clinical trials Expert Opinion on Emerging Drugs January 2, 2021
- The Benzydamine Experience: A Systematic Review of Benzydamine Abuse Current Neuropharmacology January 14, 2021
- A Qualitative Analysis of First-Hand Accounts of Diphenhydramine Misuse Available on YouTube Journal of Psychoactive Drugs August 31, 2023
- Concomitant use of dextromethorphan and alcohol-induced dissociation in a patient with alcohol dependence. Psychiatry and Clinical Neurosciences Reports December 1, 2024
and 3 more in the library
Cites 4
- From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs. Drug Testing and Analysis 2014
- Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders. Pharmacology & Therapeutics March 1, 2016
- Dextromethorphan psychosis, dependence and physical withdrawal. Addiction Biology December 1, 2005
- Adolescent Abuse of Dextromethorphan Clinical Pediatrics September 1, 2005